In order to assess risks more fully, the Food and Drug Administration (FDA) initiated hearings on whether the drug label for Trasylol should be expanded to include these risks.
comments Discuss   addto Add this link to...  recommend Tell a friend   report Bury

Comments Who Gave Cookies? Related Links